Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Inpegsomatropin by Xiamen Amoytop Biotech for Born Small For Gestational Age (SGA): Likelihood of Approval
Inpegsomatropin is under clinical development by Xiamen Amoytop Biotech and currently in Phase II for Born Small For Gestational Age...
Inpegsomatropin by Xiamen Amoytop Biotech for Turner Syndrome: Likelihood of Approval
Inpegsomatropin is under clinical development by Xiamen Amoytop Biotech and currently in Phase II for Turner Syndrome. According to GlobalData,...
Inpegsomatropin by Xiamen Amoytop Biotech for Idiopathic Short Stature: Likelihood of Approval
Inpegsomatropin is under clinical development by Xiamen Amoytop Biotech and currently in Phase II for Idiopathic Short Stature. According to...